Respiratory Support Techniques in Critical Care Medicine

Learning Objectives

• Differentiate the major mechanical ventilation modes and describe when each is used
• Explain the components of lung-protective ventilation and why they reduce ventilator-induced lung injury
• Compare non-invasive ventilation (CPAP, BiPAP, HFNC) with invasive mechanical ventilation and identify indications/contraindications for each
• Select an appropriate oxygen delivery device based on a patient's FiO2 requirement and clinical status
• Recognize and manage major complications of mechanical ventilation
• Apply spontaneous breathing trial criteria to judge ventilator weaning readiness

Quick Answer

Respiratory support techniques are the interventions ICU teams use to maintain oxygenation and ventilation when a patient's own lungs can't keep up — ranging from simple nasal cannula oxygen, to non-invasive ventilation (CPAP/BiPAP), to full invasive mechanical ventilation via endotracheal tube. The choice depends on the severity of respiratory failure, the underlying cause, and the patient's ability to protect their airway. Modern practice emphasizes lung-protective ventilation (low tidal volumes, controlled plateau pressures) to avoid worsening lung injury, and structured weaning protocols to liberate patients from the ventilator as soon as safely possible. Getting the mode, settings, and timing right is one of the highest-yield skills in critical care because ventilator mismanagement itself is a major cause of morbidity.

Why Respiratory Support Matters

Respiratory failure is one of the most common reasons patients land in the ICU — whether from pneumonia, ARDS, COPD exacerbation, sepsis, or post-operative complications. The lungs either fail to oxygenate blood adequately (Type 1 respiratory failure, low PaO2) or fail to clear CO2 (Type 2 respiratory failure, high PaCO2), and often both happen together. Respiratory support buys time for the underlying disease to be treated, but it is not benign — the very machines that keep patients alive can also injure the lungs if used carelessly. That tension (support the patient vs. avoid iatrogenic harm) is the organizing idea behind almost every decision in this topic.

Mechanical Ventilation

Mechanical ventilation is the primary method of invasive respiratory support in critical care. A ventilator either assists a patient's own breathing effort or fully takes over the work of breathing, delivering gas through an endotracheal or tracheostomy tube.

Modes of Mechanical Ventilation

Assist-Control (AC) Ventilation

• The ventilator delivers a fixed tidal volume (volume-control) or a fixed pressure target (pressure-control) with every breath, whether it is patient-triggered or machine-triggered
• If the patient breathes faster than the set rate, every extra breath is still fully supported — this can cause "breath stacking" and hyperventilation in tachypneic patients
• Best for patients who need substantial ventilatory support, such as early ARDS or sedated post-operative patients

Synchronized Intermittent Mandatory Ventilation (SIMV)

• Delivers a set number of mandatory breaths synchronized with the patient's own effort; breaths above that rate are only partially supported (or unsupported)
• Historically used as a weaning mode, but evidence shows it can actually increase work of breathing compared to pressure support, so many ICUs have moved away from it for weaning

Pressure Support Ventilation (PSV)

• The patient triggers every breath; the ventilator only adds a set amount of inspiratory pressure to assist, and the patient controls rate, tidal volume, and inspiratory time
• Used for patients who have adequate respiratory drive and are being weaned toward extubation

Continuous Positive Airway Pressure (CPAP)

• A constant positive pressure is maintained throughout the respiratory cycle, keeping alveoli open, but the patient does all the work of breathing
• Can be delivered invasively (through an ET tube during a spontaneous breathing trial) or non-invasively via mask

A quick way to remember it: AC does the most work for the patient, PSV lets the patient do most of the work with a boost, and CPAP just keeps the airway open without adding a breath.

Lung-Protective Ventilation

This is the single most important concept in modern mechanical ventilation, born from the landmark ARDSNet trial (2000). The strategy:

• Tidal volume 4–8 mL/kg of predicted body weight (not actual weight) — typically 6 mL/kg as a starting target
• Plateau pressure kept below 30 cm H2O to limit alveolar overdistension
• Permissive hypercapnia is accepted (allowing PaCO2 to rise) if it means avoiding excessive tidal volumes
• PEEP is titrated (often via a PEEP/FiO2 table) to keep alveoli open without over-distending them

This strategy reduced mortality in ARDS patients by roughly 9% compared to traditional 12 mL/kg ventilation — one of the few interventions in critical care with such a clear, reproducible mortality benefit.

Ventilator Settings

Setting	What It Controls	Typical Starting Point
Tidal Volume (VT)	Volume of air per breath	6 mL/kg predicted body weight
Respiratory Rate (RR)	Breaths per minute	12–20/min, adjusted to pH/PaCO2
PEEP	Pressure maintained at end-expiration to prevent alveolar collapse	5 cm H2O minimum; titrated up in ARDS
FiO2	Fraction of inspired oxygen	Start high (100%) then wean to lowest FiO2 keeping SpO2 ≥ 90–92%
Inspiratory Flow/Time	Speed and duration of the breath	Adjusted for patient comfort and I:E ratio

The PEEP/FiO2 relationship matters clinically: as you increase PEEP to recruit collapsed alveoli, you can often decrease FiO2 while maintaining oxygenation — this trade-off is tracked using standardized PEEP/FiO2 tables in ARDS protocols.

Complications of Mechanical Ventilation

1. Ventilator-Induced Lung Injury (VILI) — excessive stretch (volutrauma) and shear forces from repeated opening/closing of alveoli (atelectrauma) trigger local and systemic inflammation (biotrauma), which can worsen ARDS and contribute to multi-organ dysfunction
2. Barotrauma — high airway pressures rupture alveoli, letting air track into tissues and causing pneumothorax, pneumomediastinum, or subcutaneous emphysema
3. Ventilator-Associated Pneumonia (VAP) — the endotracheal tube bypasses normal airway defenses, allowing secretions to pool above the cuff and micro-aspirate into the lungs; prevented with head-of-bed elevation, oral care, and daily sedation interruption
4. Sputum retention and mucus plugging — impaired cough and mucociliary clearance in intubated patients can lead to atelectasis or acute respiratory decompensation if not managed with suctioning and mobilization
5. Hemodynamic effects — positive pressure ventilation increases intrathoracic pressure, which reduces venous return and can drop cardiac output, especially in hypovolemic patients

Non-Invasive Ventilation (NIV)

NIV delivers ventilatory support through a mask rather than an endotracheal tube, avoiding the risks of intubation (sedation, VAP, tracheal injury) while still supporting oxygenation and ventilation.

Types of NIV

• Nasal or Full-Face CPAP — a single continuous pressure, most useful for hypoxemic conditions like cardiogenic pulmonary edema and mild ARDS
• Bi-level Positive Airway Pressure (BiPAP) — delivers a higher pressure during inspiration (IPAP) and a lower pressure during expiration (EPAP); the pressure difference actively assists ventilation, making it especially effective for CO2 clearance in COPD exacerbations
• Helmet CPAP/NIV — a transparent hood sealed at the neck; better tolerated for prolonged use and reduces air leak issues seen with tight facial masks
• High-Flow Nasal Cannula (HFNC) — delivers heated, humidified oxygen at flows up to 60 L/min with a controlled FiO2; provides a small amount of PEEP and washes out anatomical dead space, improving oxygenation without a tight-fitting mask

Indications for NIV

• COPD exacerbation with respiratory acidosis (the strongest evidence base for NIV — reduces intubation rates and mortality)
• Acute cardiogenic pulmonary edema
• Immunocompromised patients with hypoxemic respiratory failure (avoiding intubation reduces infection risk)
• Facilitating early extubation in select post-extubation high-risk patients

Contraindications to NIV

• Inability to protect the airway (decreased consciousness, vomiting risk)
• Hemodynamic instability or cardiac arrest
• Facial trauma or recent upper airway/GI surgery
• Copious secretions the patient cannot clear

Benefits of NIV

• Avoids the risks of intubation and sedation
• Reduced rates of ventilator-associated pneumonia
• Shorter ICU length of stay in appropriate candidates
• Allows the patient to eat, speak, and cooperate with therapy

Oxygen Therapy

Oxygen therapy alone — without any ventilatory assistance — is often sufficient for milder degrees of hypoxemia and is the first step in the respiratory support ladder.

Oxygen Delivery Devices

Device	Approx. FiO2 Range	Notes
Nasal Cannula	24–44%	Flow limited to ~6 L/min; simple, comfortable
Simple Face Mask	40–60%	Requires minimum flow (~5 L/min) to flush exhaled CO2
Venturi Mask	24–60% (precise)	Color-coded valves deliver an exact, fixed FiO2 — useful in COPD where over-oxygenation can suppress respiratory drive
Non-Rebreather Mask	Up to 90–95%	Reservoir bag with one-way valves; used for acute severe hypoxemia before escalation
High-Flow Nasal Cannula	Up to ~100%	Heated/humidified; best tolerated high-FiO2 option

Oxygen Therapy Considerations

• Pulse oximetry gives continuous, non-invasive SpO2 monitoring but can be inaccurate with poor perfusion, carbon monoxide poisoning, or dark nail polish
• Arterial blood gas (ABG) remains the gold standard for assessing oxygenation (PaO2), ventilation (PaCO2), and acid-base status
• Oxygen toxicity risk rises meaningfully above an FiO2 of 60% sustained for prolonged periods, causing absorption atelectasis and free-radical lung injury
• CO2 retention risk in chronic CO2 retainers (severe COPD) if oxygen is given too liberally, blunting hypoxic respiratory drive — target SpO2 88–92% in these patients rather than normalizing it to 98–100%

Airway Management

A secure, patent airway underlies every other respiratory intervention.

Endotracheal Intubation

Endotracheal intubation places a tube through the vocal cords into the trachea to secure the airway and enable invasive mechanical ventilation.

• Indications: failure to oxygenate/ventilate despite NIV, inability to protect the airway (GCS typically ≤8), anticipated clinical deterioration, airway obstruction
• Complications: esophageal intubation, aspiration, hypotension from sedative agents, dental/airway trauma, laryngospasm, and later vocal cord injury or tracheal stenosis with prolonged intubation

Suctioning Technique

Suctioning clears secretions the patient cannot cough out but carries its own risks if done poorly.

• Use sterile technique to reduce infection risk
• Limit suction duration (under 15 seconds per pass) and pre-oxygenate to avoid hypoxemia
• Use the lowest effective negative pressure to avoid mucosal trauma
• Avoid routine (rather than as-needed) suctioning, which can cause unnecessary airway irritation and bronchospasm

Tracheostomy Care

For patients needing prolonged mechanical ventilation (generally beyond ~10–14 days), tracheostomy is often preferred over continued translaryngeal intubation.

• Reduces sedation requirements and improves patient comfort compared to an ET tube
• Requires verification of correct tube placement, regular stoma and inner cannula care, and vigilant secretion management
• Decannulation is considered once the underlying reason for ventilation has resolved and the patient can protect their airway and clear secretions independently

Weaning from Mechanical Ventilation

Getting a patient off the ventilator promptly — without failing extubation — is a core ICU skill, because each extra ventilator day raises the risk of VAP, delirium, and ICU-acquired weakness.

Readiness criteria typically include:

• Resolution or improvement of the underlying cause of respiratory failure
• Adequate oxygenation (PaO2/FiO2 > 150–200 on modest FiO2/PEEP)
• Hemodynamic stability with minimal vasopressor support
• Adequate mental status and cough/gag reflex
• Ability to tolerate a spontaneous breathing trial (SBT) — typically 30–120 minutes of minimal ventilator support (low pressure support or a T-piece) while monitoring respiratory rate, tidal volume, heart rate, and SpO2

A commonly used bedside predictor is the Rapid Shallow Breathing Index (RSBI) = respiratory rate ÷ tidal volume (in liters). An RSBI under 105 during an SBT predicts a good chance of successful extubation; higher values predict failure.

Ventilator Mode Selection Pathway

Key Terms

Term	Definition	Related Concept
Assist-Control (AC)	Ventilation mode delivering full support (set volume or pressure) for every breath	Volume/pressure control, breath stacking
Pressure Support Ventilation (PSV)	Mode where the patient triggers and controls breath timing/volume; ventilator adds a set pressure boost	Weaning, work of breathing
PEEP	Positive End-Expiratory Pressure — pressure maintained at end-exhalation to prevent alveolar collapse	ARDS, lung recruitment
Plateau Pressure	Pressure measured during an inspiratory pause, reflecting alveolar distending pressure	Lung-protective ventilation, VILI
Lung-Protective Ventilation	Strategy using low tidal volume (6 mL/kg PBW) and limited plateau pressure to reduce lung injury	ARDSNet protocol
BiPAP	Bi-level positive airway pressure — different pressures for inspiration (IPAP) and expiration (EPAP)	NIV, COPD exacerbation
High-Flow Nasal Cannula (HFNC)	Heated, humidified high-flow oxygen delivery with mild PEEP effect	Hypoxemic respiratory failure
Ventilator-Induced Lung Injury (VILI)	Lung damage caused by excessive stretch, shear, or biotrauma from mechanical ventilation	Volutrauma, atelectrauma, barotrauma
Rapid Shallow Breathing Index (RSBI)	Respiratory rate divided by tidal volume (L); predicts extubation success when < 105	Spontaneous breathing trial
Spontaneous Breathing Trial (SBT)	Brief trial of minimal ventilator support used to assess extubation readiness	Ventilator weaning

Common Mistakes

Misconception: Higher tidal volumes are always better because they deliver more oxygen and "open up" the lungs more. Why it's wrong: Large tidal volumes overdistend already-compromised alveoli, causing volutrauma and triggering an inflammatory cascade (biotrauma) that worsens lung injury and increases mortality in ARDS. The ARDSNet trial showed clear mortality benefit with lower tidal volumes despite modestly higher PaCO2. Correct understanding: Lung-protective ventilation targets 4–8 mL/kg of predicted body weight (usually 6 mL/kg) with plateau pressure kept under 30 cm H2O, accepting permissive hypercapnia rather than chasing larger breaths.

Misconception: Giving a COPD patient with chronic CO2 retention as much supplemental oxygen as needed to reach a normal SpO2 (98–100%) is always the safest approach. Why it's wrong: Chronic CO2 retainers rely partly on hypoxic drive to breathe; aggressively normalizing SpO2 can blunt that drive, worsen hypercapnia, and precipitate respiratory acidosis and CO2 narcosis. Correct understanding: In known chronic CO2 retainers, target a lower SpO2 range (typically 88–92%) using titrated oxygen (Venturi mask is ideal for precision), and monitor for worsening hypercapnia on serial ABGs.

Misconception: NIV (CPAP/BiPAP) is just a "gentler" version of intubation that can be tried on almost any patient in respiratory distress to avoid intubating them. Why it's wrong: NIV requires the patient to protect their own airway, cooperate with a mask, and have adequate mental status. Using it in patients with depressed consciousness, hemodynamic instability, or copious secretions delays needed intubation and increases aspiration risk. Correct understanding: NIV is best evidenced for COPD exacerbations with respiratory acidosis and cardiogenic pulmonary edema in alert, cooperative, hemodynamically stable patients — it is a bridge, not a substitute, when those conditions aren't met.

Comparison and Connections

Feature	Invasive Mechanical Ventilation	BiPAP (NIV)	CPAP/HFNC
Airway access	Endotracheal tube/tracheostomy	Face/nasal mask or helmet	Mask or nasal cannula
Primary use case	Severe respiratory failure, airway protection needed	Hypercapnic failure (COPD exacerbation)	Hypoxemic failure (pulmonary edema, mild ARDS)
Active ventilatory assist	Yes — full control possible	Yes — pressure difference (IPAP–EPAP) assists ventilation	CPAP: no active assist, just pressure; HFNC: minimal PEEP effect
Sedation required	Usually yes	No	No
VAP risk	Present	Minimal	Minimal
Patient cooperation needed	No (can be fully sedated)	Yes	Yes

Practice Questions

Recall

1. What tidal volume target defines lung-protective ventilation, and what unit of body weight is it based on? Answer guidance: 4–8 mL/kg (commonly 6 mL/kg) of predicted body weight — not actual body weight, since predicted body weight correlates with lung size while actual weight can be skewed by edema or obesity.

2. Name the four common oxygen delivery devices and their approximate FiO2 ranges. Answer guidance: Nasal cannula (24–44%), simple face mask (40–60%), Venturi mask (24–60%, precise/fixed), non-rebreather mask (up to 90–95%).

Understanding

3. Explain why pressure support ventilation (PSV) is generally preferred over SIMV for weaning. Answer guidance: In PSV, the patient triggers and controls each breath with a pressure boost, allowing gradual, patient-driven reduction of support. SIMV's mandatory breaths can paradoxically increase work of breathing on the unsupported spontaneous breaths between mandatory breaths, making it a less physiologic weaning strategy — evidence has shown it can prolong weaning compared to PSV or daily SBTs.

4. Why does increasing PEEP sometimes allow FiO2 to be reduced while maintaining the same oxygenation? Answer guidance: PEEP keeps previously collapsed alveoli open (recruitment), increasing the surface area available for gas exchange. With more functional alveolar units participating, less inspired oxygen concentration is needed to achieve the same PaO2 — this trade-off is formalized in ARDSNet PEEP/FiO2 tables.

Application

5. A COPD patient presents with respiratory acidosis (pH 7.28, PaCO2 68) but is awake, cooperative, and hemodynamically stable. What respiratory support should be tried first, and why? Answer guidance: BiPAP (NIV) should be trialed first. The IPAP/EPAP pressure difference actively assists ventilation and helps clear CO2, and BiPAP has the strongest evidence base for reducing intubation and mortality specifically in COPD exacerbations with respiratory acidosis, provided the patient can protect their airway and cooperate with the mask.

6. A ventilated ARDS patient has a plateau pressure of 34 cm H2O on a tidal volume of 8 mL/kg PBW. What should be adjusted, and why? Answer guidance: Reduce the tidal volume (toward 6 mL/kg or lower, down to 4 mL/kg if needed) to bring plateau pressure below 30 cm H2O. Elevated plateau pressure reflects excessive alveolar distending pressure and raises the risk of barotrauma and volutrauma; permissive hypercapnia is accepted as a trade-off to keep plateau pressure safe.

Analysis

7. Compare the risks of extubating too early versus keeping a patient intubated too long. Answer guidance: Extubating too early risks reintubation, which itself carries higher mortality than a single successful extubation, plus aspiration and acute respiratory failure. Keeping a patient intubated too long increases risk of VAP, ICU-acquired weakness, delirium, longer ICU stay, and higher costs. Daily SBT assessment with objective criteria (RSBI, oxygenation, hemodynamic stability) balances these competing risks.

8. A patient's RSBI during an SBT is 130, but their oxygenation and hemodynamics look fine. Should they be extubated? Explain your reasoning using the underlying physiology. Answer guidance: No — an RSBI above 105 predicts a high likelihood of extubation failure, typically because the patient is breathing rapidly and shallowly (high RR relative to tidal volume), indicating inadequate respiratory reserve or excessive work of breathing, even if oxygenation looks adequate on the ventilator. Extubating despite a poor RSBI risks acute decompensation and emergency reintubation; it's safer to continue ventilatory support, address reversible contributors (secretions, fluid overload, weakness), and retry the SBT later.

FAQ

Why is tidal volume calculated using "predicted" body weight instead of the patient's actual weight? Lung size correlates with height and sex, not with how much a person currently weighs — a fluid-overloaded or obese patient doesn't have proportionally larger lungs. Predicted body weight formulas (based on height and sex) estimate the lung volume the patient should have, so tidal volume settings actually protect the lungs from overdistension rather than being skewed by edema or excess adipose tissue.

What's the practical difference between CPAP and BiPAP that determines which one to use? CPAP delivers one constant pressure throughout the breathing cycle and mainly helps with oxygenation by keeping alveoli open — it doesn't actively assist the breath itself. BiPAP alternates between a higher inspiratory pressure and lower expiratory pressure, and that pressure difference actively pushes air in, assisting ventilation and helping clear CO2. That's why BiPAP is favored for hypercapnic failure (like COPD exacerbations) while CPAP is favored for purely hypoxemic problems (like cardiogenic pulmonary edema).

Why do some patients fail a spontaneous breathing trial even though their lungs look fine on imaging? SBT failure isn't only about the lungs — it can reflect ICU-acquired weakness (from prolonged sedation, immobility, or critical illness myopathy), cardiac dysfunction unmasked by the negative intrathoracic pressure of spontaneous breathing, secretions the patient can't clear, or inadequate respiratory drive. Weaning failure is often multifactorial, which is why a full readiness assessment looks beyond oxygenation numbers alone.

Is it ever appropriate to accept a high PaCO2 on purpose? Yes — this is called permissive hypercapnia, and it's a deliberate part of lung-protective ventilation. Rather than raising tidal volume to normalize PaCO2 (which would raise plateau pressure and risk VILI), clinicians accept a higher PaCO2 as long as the resulting acidosis is tolerable (generally pH above ~7.20–7.25), since the mortality benefit of avoiding lung overdistension outweighs the modest harms of controlled hypercapnia in most patients.

Why has high-flow nasal cannula (HFNC) become so popular in recent years? HFNC delivers precisely titrated, heated, and humidified oxygen at very high flow rates, which improves comfort and tolerance compared to tight-fitting masks, provides a small PEEP effect, and washes out CO2-laden dead space in the nasopharynx. Trials (notably the FLORALI study) showed it can reduce intubation rates in hypoxemic respiratory failure compared to standard oxygen or even NIV in some populations, while being far better tolerated for prolonged use.

Quick Revision

• Ventilation modes: AC (full support every breath), SIMV (mandatory + spontaneous breaths), PSV (patient-driven with pressure boost), CPAP (pressure only, no active assist)
• Lung-protective ventilation: 6 mL/kg predicted body weight tidal volume, plateau pressure < 30 cm H2O, permissive hypercapnia accepted
• PEEP keeps alveoli open and allows FiO2 reduction; titrated via PEEP/FiO2 tables in ARDS
• BiPAP best for hypercapnic failure (COPD exacerbation); CPAP/HFNC best for hypoxemic failure (pulmonary edema, mild ARDS)
• NIV requires airway protection, cooperation, and hemodynamic stability — not for depressed consciousness or copious secretions
• Oxygen devices scale with need: nasal cannula → simple mask → Venturi mask (precise FiO2) → non-rebreather → HFNC
• COPD chronic CO2 retainers: target SpO2 88–92%, not normal saturation, to avoid blunting hypoxic drive
• VILI mechanisms: volutrauma (overdistension), atelectrauma (repeated alveolar collapse/reopening), barotrauma, biotrauma (inflammation)
• SBT readiness: resolving underlying cause, adequate oxygenation, hemodynamic stability, intact mental status/cough
• RSBI (RR/tidal volume in L) < 105 during SBT predicts successful extubation
• Tracheostomy considered for prolonged ventilation (~10–14+ days) to reduce sedation needs and improve comfort
• VAP prevention bundle: head-of-bed elevation, oral care, daily sedation interruption, early mobilization

Related Topics

Prerequisites: Respiratory physiology (gas exchange, compliance, resistance), acid-base balance and ABG interpretation, basic pharmacology of sedatives and analgesics

Related Topics: Intensive Care Unit Procedures, ARDS management, Sepsis Management in ICU, Airway Management and Difficult Airway, Ventilator-Associated Pneumonia prevention

Next Topics: ARDS-specific management strategies, Cardiovascular Support Techniques, ABCDEF bundle and sedation management, ECMO for refractory respiratory failure